chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received a 0.5mL booster; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (received a 0.5mL booster) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (received a 0.5mL booster). At the time of the report, ACCIDENTAL OVERDOSE (received a 0.5mL booster) had resolved.            Patient age is over 65 years old. Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-365034 (Patient Link).
The area of the inject on my upper arm was swelled up and I felt pain for about 2 days before then my arthritis increased. The 2 nails swelled up which was strange observation I witness. On the 3rd day the pain reduced and the swelling on my arm disappeared.
Extreme chills, fever (lasted up to 24 hours), exhaustion, huge swollen bump over shot injection site, rash down left arm, swollen lymph node in left armpit where shot was administered
Within minutes had funny test in mouth ,body aches ,headaches, chills , fever, vomiting , diarrhea.  Me and my wife and mother in-law all had these symptoms . but we all had Covd-19 2 months ago
Within 10 minutes of getting the shot I noticed a progression of symptoms that increased and got worse. I got very hot. I was sweating. I was very light headed. I got a headache. I was nauseous. I believed I was going to faint. My blood pressure spiked.   I noticed getting hotter and hotter  within 5 or 10 minutes of the shot. I removed some outer clothing, but I still kept getting hotter.  Then I noticed I was very light headed. Then I noticed I was sweating. I was very clammy and later on, a woman attendant said she could see the sweat on my. The headache began in the back of my neck. I thought I was going to faint. I because nauseous. My thinking became unclear.  After about 15 minutes of this continuing to get worse, I called over the paramedics. They took my blood pressure and said it was very high. They checked my heart beat, oxygen level, lungs, and blood pressure. They checked my blood pressure again, and then again maybe 15 or so minutes after the second time and they reported to me that it was going down. I continued to not feel well and the worst of it lasted for about an hour and now, 2 full days later I still do not feel well.   Yesterday, 1 day after the shot, I barely got off the couch.   Today, my vision is blurry, I am still light headed, and still feel dizzy. My headache has diminished. My thinking is still foggy.  I do not feel safe to drive.  As far as treatment, I just sat still. I had eaten breakfast and lunch (ate lunch within an hour of the shot, but was given a ginger all and 2 cookies, which I ate. After I felt well enough to get up, I walked around the facility for a few minutes, then I went outside in the cold fresh air and continued to walk for a bit. I then drove home and stayed on the couch.   I do want to state (and no where on here does it ask about this) so I am putting it here: I have only ever gotten a small pox and polio vaccination as a child, a Hep B shot four decades ago, and tetanus/whooping cough shots. I also take no medications and throughout my lifetime I have only taken a few.  So, when the early pre-vaccine assessments ask about allergic reactions to injections of vaccines, I answered no because I barely ever had any. No pre-vaccination assessments also said that no adverse reactions to oral medications were a problem. And there was no where in the early assessments to give u that info. I did say, yes, about having immune system issues on the online assessment, and I told the attendant at the time of check in. It is unidentified as far as it having a name, but I have seen a Rheumatologist last spring and she ruled out Lupis. I get sick easily with colds, so I believe I have a weak immune system.
(R) deltoid induration, warmth, tenderness. Area of about 2 1/2 x 3 1/2 in. Per patient, red streaks up to neck yesterday, mild fever. Resolved with ice and NSAIDS.
Sob, anxiety Tx: None, vital signs taken. 1 hour observation pd, allergy review recommended  No reactions noted after 1 hr observation and RTW Received 2nd injection 1/16/21
fever, diarrhea, lethargic x 12 hrs , vaginal spotting and pelvic cramping x 2 weeks
Vaccine #1 - slight fatigue and muscle aches; 10 days after vaccine, developed redness and itchiness at site of vaccine and back of throat itchy  Vaccine #2 - extreme fatigue and muscle aches; arm soreness; headache; lightheaded.  Day #2 developed lip swelling, swelling under eye, heart racing; insomnia for 36 hours (not enough to go to ER).  At the end of the 48 hour period after vaccine, developed tightness in the chest.
Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old); This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old)) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old)). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: The follow-up was received on 9-JUN-2021 and has no new information.
Rash on her arm; This spontaneous case was reported by a nurse and describes the occurrence of RASH (Rash on her arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced RASH (Rash on her arm). At the time of the report, RASH (Rash on her arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Updated the outcome of event Rash(from not recovered to recovered).Declined further followup.
I went to see the doctor because I noticed that it made my vertigo really bad. I don't have vertigo on a daily basis anymore as my medication was adjusted to keep me from having issues with my vertigo. I was dizzy every day and an occasional migraine. I went to see my doctor because I noticed that it made my vertigo really bad. I don't have vertigo on a daily basis anymore as my medication was adjusted to keep me from having issues with my vertigo. I was dizzy every day and an occasional migraine. I went to see my doctor in November of 2022. They didn't do any test, but they examined me since I already had a diagnosis of vertigo. There was nothing that could be done to help me as I had already had my medication altered to the point it was not bothering. It made me feel really sick and depressed. I began to feel like I was at the beginning stages of Dementia. Over time the extreme vertigo symptoms got better. It was not extreme any more or daily. They didn't do any test, but they examined me since I already had a diagnosis of vertigo. There was nothing that could be done to help me as I had already had my medication altered to the point it was not bothering. It made me feel really sick and depressed. I began to feel like I was at the beginning stages of Dementia. Over time the extreme vertigo symptoms got better. It was not extreme any more or daily.
Blood clotting originating near the injection site led to a stroke about two or so weeks after the second Pfizer dose. Memory and motor skills have been impaired ever since.
Patient stated that when he left the vaccination area, he felt a pain in his lower right back. He stated he has had muscular issues in that area before, but this felt like a nerve pain radiating up his back. He said within 5 minutes all pain was gone. He thought it may have been due to the vaccination.
Dizziness, lightheadedness, sweating, blurry vision, nausea immediately following injection. Later that day/evening patient developed rheumatoid arthritis flair up that resolved over the course of two days and use of prescription medications (diphenhydramine and  prednisone).   Patient has a long standing history of rheumatoid arthritis.
COVID 19; COVID 19; Moderna, Date: 10Oct2021, Dose Number: 3 / Pfizer, Date: 06May2022, Dose Number: 4; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 70-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 at 16:00 as dose 5 (booster), single (Lot number: GH9693) at the age of 69 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 06May2022 at 14:00 as dose 4 (booster), single (Lot number: FJ4989), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 29Jan2021 at 14:00 as dose 1, single (Lot number: 028L20A), in left arm, on 26Feb2021 at 14:00 as dose 2, single (Lot number: 031L20A), in left arm and on 10Oct2021 at 14:00 as dose 3 (booster), single (Lot number: 020F21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 06May2022 at 14:00, outcome "unknown", described as "Moderna, Date: 10Oct2021, Dose Number: 3 / Pfizer, Date: 06May2022, Dose Number: 4"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) Positive, notes: Rebound 4 day after completing 5 day course of Paxlovid COVID test positive again and symptoms returned. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid.
Metallic taste in mouth started about 15 minutes aftr the shot was administered 8/19/15 until around 2 am on 8/20/15. Note: Has never had this taste before other than when she started toTOPAMAX in 2008. Tasted lasted a few months after TOPAMAX.
Low grade fever, chills, malaise, headache, loss of appetite, unable to sleep.  14 hours for each.
Swelling of the throat.  Oxygen did not stop below 95.  Resolved most of the way with benadryl.    Headache.
This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. There were no concurrent conditions, medical history and concomitant medications reported. On an unknown date, the patients were vaccinated with improperly stored M-M-R II (dose, route of administration, lot# and expiration date were not reported). There were no adverse symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a pharmacist referring an unknown number of patients of unknown age and gender. The patients' pertinent medical histories, concurrent conditions and concomitant medications were not reported. On an unknown date, the unspecified patients were vaccinated with a dose of PNEUMOVAX 23 (Dose, route, lot # and expiration date were not reported). It was stated that the patients experienced one or all of the following events: injection site pain, injection site erythema and/or injection site swelling, after vaccination. At the time of reporting the outcome of injection site pain, injection site erythema and injection site swelling was unknown. The reporter did not assess the causal relationship between the adverse events and the vaccination with PNEUMOVAX 23. This is one of several reports from the same reporter. Additional information has been requested.
After waiting for about 15 minutes after her second dose, the patient complained of tongue swelling and difficulty breathing.  The Pharmacist on duty looked in the patient's mouth and did not notice any tongue swelling but suggested to call 911 because of the breathing issue.  The patient agreed and 911 was called. The local Fire Dept. came and checked the patient's blood pressure and examined her.  She checked out ok according to the Fire Dept.  The Fire Dept. left  the pharmacy and the patient called her boyfriend to come and pick her up.  The patient walked away on her own power after her boyfriend came to get her at the pharmacy.
A report has been received from a Physician concerning a 3 year old, Female subject. FLUMIST quadrivalent (intranasal) was administrated to the sister of the patient. The patient had exposure to vaccinated person and experienced fever, headache, stuffy nose. The outcome of the event of fever, headache, stuffy nose and exposure to vaccinated person is unknown. The report was considered to be non-serious.
INJECTION ADMINISTERED 9/26/23 AND PATIENT NOTICED HER ARM WAS SORE, SWOLLEN WITH SLIGHT FIRMNESS AND RED CIRCULAR RING AROUND INJECTION SITE OF LEFT ARM ON 9/27/23.  PATIENT HAS BEEN ICING ARM AND TAKING MOTRIN FOR SWELLING.
Developed a rash on her chest called shingles; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-May-2021 and was forwarded to Moderna on 02-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Developed a rash on her chest called shingles) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A 21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Developed a rash on her chest called shingles). At the time of the report, HERPES ZOSTER (Developed a rash on her chest called shingles) was resolving.            Concomitant medications were not reported.  No treatment details were provided
Lump at injection site, red hot, swollen rash approx 6 inches x 3 inches, hard spots in the muscles aching, itchy for 3 days. Lump at site still there after a week and a half. Rash lessened over the week.
this is what employee emailed: "The first night I experienced lightheadedness/ dizziness followed by cold sweats around 11pm-12am with a fever of 99.6 that eventually broke by morning around 5am-6am. Also experienced lower back pain throughout the first night. Now the second day I have woken up with some left sided chest discomfort, worsens when taking a deep breath. I would like to make sure that this is documented on my file. I have heard of these kinds of symptoms on the 2nd dose but not the 1st."
At the time of the injection I got very dizzy lost the color in my face had ringing in my ears that lasted about 15 minutes. I also lost my vision for a few seconds. About 6 hours after the injection I have pain in my left shoulder and left upper are that has not subsided as of 07/29/2008.
Pt recvd DTP/OPV/HBOC 16MAR92 & on 11PM 16MAR92 pt sleeping in crib mom left room & returned to find pt hot & convulsing; mom gave tempra for fever; taken to Er & fever was 103.8 R: MD felt poss rxn to pertussiss-no further pertussis;
Itching on back, neck, and arms.  Redness and blotchiness on same areas. Administered Benadryl 25mg PO and symptoms resolved within 30 minutes.
Fever; cold/night sweats; cold/night sweats; severe headache; body aches; horrible fatigue; Neutrophils - 37% (L); Lymphocytes - 46.7 % (H); Hemoglobin A1c - 5.9 % (H); syncope each morning upon rising -- less each day (first morning after vaccine the worst), lasted for 5 days.; Third shot; Third shot; This is a spontaneous report from a contactable consumer (patient).   A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 3 via an unspecified route of administration, administered in Arm Left on 06Feb2021 (PENDING CLASSIFICATION, Batch/Lot Number: aw0175), at the age of 61 years old, as DOSE 3, SINGLE for covid-19 immunisation. The patient received the first dose of BNT162B2 on 06Feb2021 (PENDING CLASSIFICATION, at the age of 61 years old), Lot no: ema9809 for COVID-19 immunization and experienced Fatigue, headache, body aches x 3 days, then one day normal, then 1 days of fatigue. The patient received the second dose of BNT162B2 on 06Feb2021 (PENDING CLASSIFICATION, at the age of 61 years old), Lot no: en6202 for COVID-19 immunization and experienced Fatigue, headache, body aches x 4 days. Then one day normal, then 2 days of fatigue. Patient had allergies to Levaquin, Meloxicam, Codeine. Medical history included Sjogrens Syndrome, Asthma, Rheumatism, Arthritis, Radiation enteritis, migraine, periodic chronic fatigue. Unspecified concomitant medication was reported. Patient experienced on 27Aug2021 19:00 fever, cold/night sweats, severe headache, body aches, horrible fatigue, syncope each morning upon rising -- less each day (first morning after vaccine the worst), lasted for 5 days. Fatigue, body aches, headache lasted 10 days. NEUTROPHILS - 37% (L) LYMPHOCYTES - 46.7 % (H) HEMOGLOBIN A1C - 5.9 % (H) Normally these tests are normal for me. No treatment received. Events resulted in Physician Office Visit. Outcome of events was recovered in 2021.
Left arm - numbness elbow down to little finger. Swelling at injection site, eyes light sensitive. Body aches, lethargy, sore throat & mouth, cough.
Patient had a rash/hives on her lower left leg shortly after receiving Pfizer-BioNTech Covid-19 vaccination (5:45 pm).  Patient, along with her parent, was monitored for 30 minutes.  After 30 minutes, patient's mom stated that the rash seems to have improved and that she was contacting pediatrician to see if any further treatment was necessary.  Patient's mom indicated that patient is also allergic to Benadryl.  Patient and her mom left at 6:20 pm, stating that they thought the patient was fine and was okay to leave.
Patient complained of significant arm pain after having 2 vaccines administered. Pt believed that the intern who administered the shot was too high on the arm near the shoulder
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) in 2010, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-MAY-2016, the patient began to break out with blistering vesicular lesions. The patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The patient broke out consistently in blistering lesions for more than one year in duration. The patient was further treated at an eye clinic throughout 2016 for shingles interference in the eye. The patient was also treated extensively by a dermatologist for her uncontrolled shingles symptoms, including attempts to treat her shingles with experimental onabotulinumtoxinA (BOTOX) treatments. She was referred to a rigorous chiropractor and acupuncture treatment plan for alternative methods to attempt to curb her terrible symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, shingles interference in the eye was determined to be medically significant. Additional information has been requested.
tingling nerve pain; itching; rash on arm and body; tingling nerve pain; This case was reported by a consumer via call center representative and described the occurrence of nerve pain in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included breast cancer. Concomitant products included denosumab (Prolia).   In December 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced nerve pain, pruritus, generalized rash and tingling sensation. On an unknown date, the outcome of the nerve pain, pruritus, generalized rash and tingling sensation were unknown.   It was unknown if the reporter considered the nerve pain, pruritus, generalized rash and tingling sensation to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient who had her second dose of Shingrix in early Dec 2019 on left arm.   Caller reports that she experienced rash on her left arm around end of Dec 2019 or beginning of Jan 2020 that spread across rest of her body.  Caller reports that she also had itching and tingling nerve pain nerve pain associated with the rash. The reporter consented to follow up.
The patient presented to the clinic the day after vaccination with mom with c/o sore arm, hand/leg cramps/ fatigue, and states that she feels like her "heart may be fluttering" some.
I experienced tenderness at the site of injection immediately and it increased during the next few hours to more severe pain and restricted movement of the shoulder (Inability to raise arm above 30 degrees) combined with  intermittent mild numbness and tingling in arm to fingers.  I treated the pain with ice and acetaminophen combined with my scheduled meloxicam.  The pain remain unchanged for 72 hours but is now is subsiding with continued use of acetaminophen, meloxicam and heat.  As of today, 3 weeks after injection,  I have regained complete range of motion of the arm except with some pain yet when shoulder rotates posteriorly.